Description
OPA1 Blocking Peptide; specific to RA25019.
This gene product is a nuclear-encoded mitochondrial protein with similarity to dynamin-related GTPases. It is a component of the mitochondrial network. Mutations in this gene have been associated with optic atrophy type 1, which is a dominantly inherited optic neuropathy resulting in progressive loss of visual acuity, leading in many cases to legal blindness. Eight transcript variants encoding different isoforms, resulting from alternative splicing of exon 4 and two novel exons named 4b and 5b, have been reported for this gene.
You'll also need
What this product needs to grow and work as described.
- OPA1RA25019 · 100 ul$670.00
Related products
- Alpha 2a Adrenergic Receptor
- Alpha 2c Adrenergic Receptor
- ASIC Beta
- CCK A Receptor
- CD39 Blocking Peptide
- Delta Opioid Receptor 3-17
- Delta Opioid Receptor 361-372
- Delta Opioid Receptor 358-372
- LepRb/OBRb
- mGluR2/3
- mGluR6
- Mu Opioid Receptor Blocking Peptide
For research use only. Not for diagnostic or clinical use.

